Organogenesis Holdings (ORGO) Current Leases (2017 - 2026)
Organogenesis Holdings' (ORGO) quarterly Current Leases came in at $4.8 million in Q1 2026, up 9.44% year-on-year from $4.4 million in Q1 2025, and down 3.74% quarter-over-quarter from $4.9 million in Q4 2025.
Organogenesis Holdings (ORGO) Current Leases (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Current Leases history runs 10 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- On a quarterly basis, Current Leases rose 9.44% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 9.44% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 322.99% from the prior year.
- Current Leases fell to $4.8 million in Q1 2026 per ORGO's latest filing, from $4.9 million in the prior quarter.
- Across five years, Current Leases topped out at $13.0 million in Q3 2023 and bottomed at $101000.0 in Q1 2022.
- The 5-year median for Current Leases is $4.7 million (2023), against an average of $4.9 million.
- Across the five-year window, Current Leases surged 4253.5% in 2022 and sank 98.24% in 2023, its largest moves.
- Year by year, Current Leases stood at $8.7 million in 2022, then tumbled by 45.66% to $4.7 million in 2023, then plunged by 75.27% to $1.2 million in 2024, then jumped by 322.99% to $4.9 million in 2025, then slipped by 3.74% to $4.8 million in 2026.
- Per Business Quant, the three latest ORGO Current Leases figures stand at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $4.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76 Mn |
| Dec 31, 2025 | 4.95 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 4.08 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 4.73 Mn |
| Sep 30, 2023 | 13.05 Mn |
| Jun 30, 2023 | 209,000.00 |
| Mar 31, 2023 | 611,000.00 |
| Dec 31, 2022 | 8.71 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 101,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 8.53 Mn |
| Jun 30, 2021 | 4.50 Mn |